ArticleJournal of pharmacology & pharmacotherapeutics
Why the Jan Aushadhi Scheme Has Lost Its Steam in India?
Article in Journal of pharmacology & pharmacotherapeutics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 25 citations in OpenAlex.
- Medicine affordability and access in India: lessons from generic-branded price variation under the Jan Aushadhi Scheme.Frontiers in public health · 2025Observational
- Genesis of People's Medicine Centre (PMC) for popularisation of generic medicine: A critical qualitative inquiry.Exploratory research in clinical and social pharmacy · 2024Article
- Using 17Journal of diabetes and metabolic disorders · 2023Article
- Intra-urban differentials in the exclusive use of hygienic methods during menstruation among young women in India.PLOS global public health · 2023Article
- Improving access to medicines by popularising generics: a study of 'India's People's Medicine' scheme in two districts of Maharashtra.BMC health services research · 2022Article
- Assessment of e-aushadhi program (drug inventory e-health initiative in Rajasthan) using benefit evaluation framework.Journal of family medicine and primary care · 2022Article
- Article
- Factors affecting self-medication practices among people living with type 2 diabetes in India- A systematic review.Metabolism open · 2021Article
- Article
- Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study.Journal of pharmaceutical policy and practice · 2019Article
- The rise of E-pharmacy in India: Benefits, challenges, and the road ahead.Indian journal of pharmacologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Jan Aushadhi Scheme (JAS) initiated by the Government of India is a powerful intervention against the unjustifiable pricing of medicines by private pharmaceutical industry, to make the generic medicines available at affordable prices. The marginalized populations of India are not able to afford many branded medicines; hence, there is an urgent need for making the cheaper generics available to Indians in the best interest of populations. It has been observed that lack of awareness in the public, distribution of free medicines by state governments, lack of support for JAS, poor supply chain, and doctors not prescribing generic medicines are the major constraints faced by the JAS leading to its poor success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.